Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.
-
Upload
daniela-barber -
Category
Documents
-
view
309 -
download
11
Transcript of Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.
![Page 1: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/1.jpg)
Hypolipidemic Drugs and plasma
expanders
Dr. Rishi PalAssistant Prof.
Deptt. of Pharmacology
![Page 2: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/2.jpg)
Cholesterol
• Critical substrate for the body:– Fundamental building block of steroid
hormones
– Essential for building cell membranes, the myelin sheath, and the brain
– Core component of bile salts, which helps in digest dietary fats
29-2
![Page 3: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/3.jpg)
Lipoproteins• There are several
different lipoproteins:
– Low-density lipoprotein (LDL)
– Very-low-density lipoprotein (VLDL)
– High-density lipoprotein (HDL)
29-3
![Page 4: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/4.jpg)
Triglycerides
• Main form of fat from diet
• Provide body with energy
• Chylomicrons: – Very large lipoproteins that deliver
triglycerides to muscle and fat tissue
29-4
![Page 5: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/5.jpg)
© 2012 The McGraw-Hill Companies, Inc. All rights reserved.
1-5
![Page 6: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/6.jpg)
© 2012 The McGraw-Hill Companies, Inc. All rights reserved.
1-6
![Page 7: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/7.jpg)
Hypolipidemic Drugs
• There are five groups of drugs used in the management of hyperlipidemia:
– HMG-CoA reductase inhibitors
– Cholesterol absorption inhibitors
– Bile acid sequestrants– Fibric acid derivatives– Nicotinic acid
29-7
![Page 8: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/8.jpg)
© 2012 The McGraw-Hill Companies, Inc. All rights reserved.
1-8
![Page 9: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/9.jpg)
© 2012 The McGraw-Hill Companies, Inc. All rights reserved.
Atherosclerosis
• Atherosclerosis is a progressive condition that leads to CAD and PAD.
• Fat buildup inside the arteries—plaque • CAD—coronary artery
disease• PAD—peripheral
artery disease
29-9
![Page 10: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/10.jpg)
© 2012 The McGraw-Hill Companies, Inc. All rights reserved.
1-10
![Page 11: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/11.jpg)
© 2012 The McGraw-Hill Companies, Inc. All rights reserved.
Atherosclerosis
• There are two types of plaque buildup:
– Stable
– Unstable
• Plaque buildup can block arteries, causing:
– Angina
– TIA
– Stroke
– Intermittent claudication
29-11
![Page 12: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/12.jpg)
Monitoring the Disease• Risk factors for
atherosclerosis– Age– History of smoking– Hypertension– Premature menopause– Obesity– Diabetes mellitus– Hyperthyroidism
29-12
![Page 13: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/13.jpg)
Monitoring the Disease
• The goals of treatment are:
– Lowering LDL cholesterol
– Reducing total serum cholesterol and triglycerides
– Increasing HDL cholesterol
29-13
![Page 14: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/14.jpg)
© 2012 The McGraw-Hill Companies, Inc. All rights reserved.
1-14
![Page 15: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/15.jpg)
HMG-CoA Reductase inhibitors
• Atorvasatatin
• Simvastatin
• Lovastatin
• Pravastatin
• Fluavastatin
• Rosuvastatin
![Page 16: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/16.jpg)
Bile acid binding resins
• Cholestyramine
• Colestipol
• Colesevelam
![Page 17: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/17.jpg)
Intestinal cholesterol absorption inhibitors
• Stanol esters
• Ezetimibe
![Page 18: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/18.jpg)
Activators of lipoprotein lipase (Fibrates)
• Gemfibrozil
• Benafibrate
• Fenofibrate
• Ciprofibrate
![Page 19: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/19.jpg)
Inhibitor of VLDL secretion and lipolysis
• Niacin (Nicotinic acid)
Miscellaneous: Gugulipid and fish oil derivatives
![Page 20: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/20.jpg)
© 2012 The McGraw-Hill Companies, Inc. All rights reserved.
Fibrates
Others
Resins
Statins
LIPID-LOWERING DRUGS
![Page 21: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/21.jpg)
HMG-CoA Reductase Inhibitors• Also referred to as statins• MOA—inhibit enzyme that causes
cholesterol synthesis
• IND—adjunct to dietary treatment to decrease total serum and LDL cholesterol:– Reduce LDL level up to 30%– Raise HDL level up to 20%
29-21
![Page 22: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/22.jpg)
HMG-CoA Reductase Inhibitors• An early, very important step in this process is
the conversion of acetyl-CoA molecules into HMG-CoA, which is then converted to mevalonic acid by HMG-CoA reductase. Mevalonic acid is a rate-limiting pivotal step in steroid and cholesterol biosynthesis
• The liver makes two-thirds of the daily cholesterol requirement.
1-22
![Page 23: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/23.jpg)
HMG-CoA Reductase Inhibitor• All of the statins reduce LDL up to 30 percent. When a
greater reduction of LDL is required, simvastatin (Zocor), atorvastatin (Lipitor), and rosuvastatin (Crestor) reduce more than 45 percent; in fact, rosuvastatin and atorvastatin have been demonstrated to reduce up to 60 percent.
• All of the statins raise the HDL level up to 20 percent. Again, simvastatin (Zocor), atorvastatin (Lipitor), and rosuvastatin (Crestor) increase HDL more than 30 percent.
1-23
![Page 24: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/24.jpg)
© 2012 The McGraw-Hill Companies, Inc. All rights reserved.
1-24
![Page 25: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/25.jpg)
HMG-CoA Reductase Inhibitors
• Adverse effects:– Headache, dizziness, alteration of taste,
insomnia, abdominal cramping and photosensitivity
• May cause myalgias, leg ache, and muscle weakness
• Contraindicated during pregancy
29-25
![Page 26: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/26.jpg)
Cholesterol Absorption Inhibitors
• Ezetimibe:– MOA—blocks absorption of cholesterol
in the intestines • Decreases VLDL • Decreases circulating LDL cholesterol
– IND—treatment of hyperlipidemia in conjunction with diet alteration
29-26
![Page 27: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/27.jpg)
Cholesterol Absorption Inhibitors
• Ezetimibe:– Modestly reduces total cholesterol, LDL,
and triglyceride blood levels– Ideal to combine with other hypolipidemic
drugs– Adverse effects—abdominal pain, fatigue,
coughing, diarrhea, back pain, and arthralgia
29-27
![Page 28: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/28.jpg)
Bile Acid Sequestrants
• MOA—bind bile salts and cholesterol in the GI tract, preventing absorption of both
• IND—hyperlipidemia:– Increased elimination of bile salts, cholesterol, and
other fats in the faeces.– Adverse effects include GI disturbances, severe
constipation, and fecal impaction.– Most serious adverse effect is intestinal
obstruction.
29-28
![Page 29: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/29.jpg)
Nicotinic Acid• MOA—affects cholesterol synthesis
through a G proteins coupled receptor:– Inhibits triglyceride lipase– Stimulates lipoprotein lipase– Decreases free fatty acid release and
removes triglycerides
• IND—hyperlipidemia
• Adverse effects—flushing, nausea, vomiting, and diarrhea
29-29
![Page 30: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/30.jpg)
Fibric Acid Derivatives (Fibrates)
• Gemfibrozil: – MOA—inhibits breakdown of fat into
triglycerides, and limits liver production of triglycerides
– IND—to decrease triglycerides
– Adverse effects—nausea, vomiting, diarrhea, and flatulence
29-30
![Page 31: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/31.jpg)
Gugulipid
• Consists of Z and E gugulsterone
• Inhibit cholestrol biosynthesis and also enhance rate of cholesterol excretion
• Dose 25 mg 3 times a day
• Reduced total CH, LDL-C with an elevation of HDL-C
• It is well tolerated, no side effect, except loose stool
![Page 32: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/32.jpg)
Fish oil derivative
• Omega-3-fatty acids
• Eicosa-pentanoic and docosa-hexanoic acid
• Prophylaxis use in high risk patient of CAD
• Usually formulated with vit.E
![Page 33: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/33.jpg)
Combination drug therapy
• Bile acid binding resins+Fibrates
• Bile acid binding resins+Niacin
• Bile acid binding resins+Statins
• Bile acid binding resins+Niacin+ Statins
• Niacin+Statin (Atorva 10+ Nia 500)
• Statins+Ezetimibe
• Statins+Fibrate
![Page 34: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/34.jpg)
Hypolipidemic Drugs
29-34
![Page 35: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/35.jpg)
Preferred Therapy
• All hypolipidemic drugs are indicated as adjunctive therapy to reduce elevated cholesterol levels.
• HMG-CoA reductase inhibitors are the most prescribed.
• Cholestyramine can also be used in the treatment of partial biliary obstruction.
29-35
![Page 36: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/36.jpg)
Contraindications• Systemic hypolipidemic drugs should not
be used in patients with liver dysfunction.
• Bile acid sequestrants should not be used in patients with biliary obstruction.
• Statins should not be used in pregnant women.
29-36
![Page 37: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/37.jpg)
Drug Interactions
29-37
![Page 38: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/38.jpg)
New drugs
• Cholesteryl ester transfer protein (CETP)
• Torcetrapib
• Anacetrapib
![Page 39: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/39.jpg)
Blood substitutes and plasma expenders
![Page 40: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/40.jpg)
Hypovolaemia
• Shock is a state of acute circulatory failure
• So, it is essential to restore intravascular blood volume as quickly as possible
• Intravenous fluid therapy
![Page 41: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/41.jpg)
Types of fluid used for replacement
• Whole blood and plasma
• Plasma substitute:• a) Colloidal: Dextran, hydroxyethyl starch
polyvenyl pyrrolidone, oxypolygelatin.
b) crystalline: NaCl, dextrose solution
![Page 42: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/42.jpg)
Desirable properties of plasma expenders
1. Should exert oncotic pressure comparable to plasma.
2. Should retain in circulation and not leak out in tissues or too rapidly disposed.
3. Should be pharmacodynamically inert.
4. Should not be pyrogenic or antigenic
5. Should not interfere with grouping and cross matching of blood.
6. Should be stable and easily sterilizable and cheap.
![Page 43: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/43.jpg)
Substance employed are
• Human albumin
• Dextran
• Polygeline
• Hetastarch
![Page 44: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/44.jpg)
Albumin
• 100ml of 20% human albumin solution is osmotic equivalent of about 400ml of fresh frozen plasma or 800 ml of whole blood.
• Not interfere with blood group and coagulation process.
• Crystalloid solutions must be infused concurrently for optimum benefit.
• It is expensive.
![Page 45: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/45.jpg)
Dextran
• Dextran-40: 10% in dextrose or in NaCl
• Dextran-70, expends plasma volume for 24 hr.
• 500-1000 ml in 30 min. and 100 ml by continuous infusion for 2-3 days.
• Be careful in patients of Renal impairment, CHF or Polycythaemia.
• Dextran-70 & dextran 110: 6% in dextrose or in NaCl, used for hypovolaemic or haemorrhagic shock
![Page 46: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/46.jpg)
Polyvenylpyrrolidone
• It is synthetic water soluble preparation with MW 35,000-40,000.
• It is sterile solution in buffered physiological saline
• It has tendency to bind with insulin and penicillin
![Page 47: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/47.jpg)
Gelatin
• MW 30,000
• 500-1000 ml of 3.5-4% used in low blood volume
• Expends plasma volume for 12 hr
• More expensive than dextran
![Page 48: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/48.jpg)
Contraindications
• Severe anemia
• Cardiac failure
• Pulmonary edema
• Liver disease
• Renal insufficiency
![Page 49: Hypolipidemic Drugs and plasma expanders Dr. Rishi Pal Assistant Prof. Deptt. of Pharmacology.](https://reader033.fdocuments.us/reader033/viewer/2022061413/56649f485503460f94c6a104/html5/thumbnails/49.jpg)
Electrolyte and water replacement
• Normal saline (0.9%)
• Dextrose 5%